Clinical Trials Logo

Information Seeking Behavior clinical trials

View clinical trials related to Information Seeking Behavior.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05937646 Recruiting - Critical Care Clinical Trials

Improving Providers' Decision-Making and Reducing Information Overload Using Information Visualization in EHRs

Start date: July 24, 2023
Phase: N/A
Study type: Interventional

This study aims to test the efficacy of an information visualization dashboard on decision-making using a randomized controlled trial with crossover. This study aims to test the efficacy of using an information visualization dashboard on ICU providers' decision-making, efficiency, and performance compared to their institutional EHR through a randomized control trial with crossover.

NCT ID: NCT04497441 Recruiting - Covid19 Clinical Trials

Netizens' Perception of COVID-19 Information & Information Sources.

Start date: June 10, 2020
Phase:
Study type: Observational

COVID-19 Infection was characterized as a Pandemic by WHO on the 11th of March 2020.1 After this there were all possible worldwide efforts to increase awareness in the general population about the COVID-19 Infection signs, symptoms, mode of transmission and prevention. The information was spread across all possible mass media communication channels. There were constant updates regarding the data of newly infected cases, deaths, and recoveries. This cross sectional study is conducted with the following objectives: 1. To understand the netizens perception regarding the sources of information available on COVID-19. 2. To understand the netizens populations perception regarding the available information on COVID-19.

NCT ID: NCT03225820 Recruiting - Clinical trials for Information Seeking Behavior

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Start date: November 9, 2017
Phase:
Study type: Observational [Patient Registry]

(a) To explore the feasibility and utility of implementing broad preemptive pharmacogenomic result delivery in the inpatient setting across multiple institutions specifically with the goal of incorporating minority-specific pharmacogenomic information; (b) To determine whether clinical outcomes for the drug warfarin are improved in African Americans through the availability of pharmacogenomics-based dosing guidance at the point-of-care.